REVOLUTIONIZING THERAPIES FOR CHRONIC DISEASES (Theater 2, L1)

Concurrent Speaker(s)

• 

  Hongkui Deng, PhD

  Cell Biology
  Peking University, China
• 

  Jihwan Song, D Phil

  Department of Biomedical Sciences, CHA University I iPS Bio, Inc., Republic of Korea

Presenting Author(s)

• 

  Alice Del Vecchio

  Molecular Medicine
  Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Italy
• 

  Rosario Isasi, JD MPH (she/her/hers)

  Human Genetics
  University of Miami, United States
• 

  Mo Li, PhD

  Bioscience
  King Abdullah University of Science and Technology (KAUST), Saudi Arabia
• 

  Sarah Saietz, MSc, BSc (she/her/hers)

  Department of Clinical Science, Intervention and Technology (CLINTEC)
  Karolinska Institutet, Sweden

Presentations:

• Developing iPSC-Based Cell Therapy for Huntington's Disease
  

  Concurrent Speaker: Jihwan Song, D Phil – Department of Biomedical Sciences, CHA University I iPS Bio, Inc.
• “THE REGULATORY SYSTEM IS CAPABLE OF HANDLING MOST OF THE SCARY SCENARIOS THAT PEOPLE THROW UP”: KEY INFORMANT PERSPECTIVES ON PRENATAL GENE EDITING
  

  Presenting Author: Rosario Isasi, JD MPH (she/her/hers) – University of Miami
• DEVELOPMENT AND PRECLINICAL VALIDATION OF CELLTHRPE1: A STEM CELL-DERIVED RETINAL THERAPY FOR DRY AGE-RELATED MACULAR DEGENERATION
  

  Presenting Author: Sarah Kieler Saietz, MSc, BSc (she/her/hers) – Karolinska Institutet
• CRISPR-CAS9-INDUCED DOUBLE-STRAND BREAKS DISRUPT MAINTENANCE OF EPIGENETIC INFORMATION
  

  Presenting Author: Mo Li, PhD – King Abdullah University of Science and Technology (KAUST)
• ENGINEERED HUMAN TUBULES REVEAL PATHOPHYSIOLOGICAL MECHANISMS OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
  

  Presenting Author: Alice Del Vecchio – Istituto di Ricerche Farmacologiche Mario Negri IRCCS
• HONGKUI DENG TITLE COMING SOON
  

  Concurrent Speaker: Hongkui Deng, PhD – Peking University